European Stroke Organisation (ESO) Guidelines on Covert Small Vessel Disease
Published by ESO on May 20, 2021
European Stroke Organisation
University of Edinburgh | ☏
made with
MAGIC
PICOS
PICO 10.1
Population
Patients with covert cerebral small vessel diseasesIntervention
Antihypertensive treatmentComparator
Less intensive or avoiding antihypertensive treatmentOutcomes
PICO 20.1
Population
Patients with covert cerebral small vessel diseaseIntervention
Antiplatelet treatmentComparator
Less intense or avoiding antiplatelet treatmentOutcomes
PICO 30.1
Population
Patients with covert small vessel diseasesIntervention
Lipid lowering treatmentComparator
Less intense or avoiding lipid lowering treatmentOutcomes
PICO 40.1
Population
Patients with covert cerebral small vessel diseasesIntervention
Physical ExerciseComparator
No Physical ExerciseOutcomes
PICO 50.1
Population
Patients with covert small vessel diseases who may (or may not) require glucose lowering therapiesIntervention
Drugs which reduce plasma glucose levelsComparator
No drugs which reduce plasma glucose levelsOutcomes
PICO 60.1
Population
Patients with covert cerebral small vessel diseasesIntervention
Conventional anti-dementia drugsComparator
Avoiding conventional anti-dementia drugsOutcomes
View
made with
MAGIC